(PharmaNewsWire.Com, October 20, 2019 ) According to the new market research report “Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.
This report studies the global mice model market for the forecast period of 2016 to 2021. This market is expected to reach USD 1.59 Billion by 2021 from USD 1.11 Billion in 2016, at a CAGR of 7.5%.
By type, the mice model market is categorized into inbred mice, genetically engineered mice, conditioned/surgically modified mice, hybrid/congenic mice, outbred mice, and spontaneous mutant mice. The inbred mice are estimated to account for the largest share of the market, by type. However, knockout mice models are expected to be the fastest-growing market segment owing to high investments in the development of new and innovative knockout models and the popularity of CRISPR as a major gene editing tool.
By technology, the market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies. Other technologies include genetically modified sperm-mediated gene transfer, virus/vector mediated gene transfer, liposome-mediated DNA & electroporation of DNA, biolistics, and TALENs & ZFN. In 2016, CRISPR technology is expected to command the largest share of the market.
Ongoing innovations in mice models, the popularity of humanized mice models, continuous support in the form of investments and grants, and growing R&D activities of pharmaceutical industries are some of the factors that are expected to drive the growth of the market in the coming years.
Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), JANVIER LABS (France), Harbour BioMed (China), TRANS GENIC, Inc. (Japan), genOway (France), and Horizon Discovery Group plc (U.S.) are some of the key players in the market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
